Sugi Predict

Sugi Predict / Compounds / SCHEMBL76125

SCHEMBL76125

SCHEMBL76125

c1ccc(N(c2ccc(-c3ccc(N(c4ccccc4)c4ccc5cc6cc7ccccc7cc6cc5c4)cc3)cc2)c2ccc3cc4cc5ccccc5cc4cc3c2)cc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.43
▸ TDP1 Q9NUW8 3/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ L3MBTL1 Q9Y468 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ KDM4E B2RXH2 1/20 0.43
▸ CYP1A2 P05177 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ ESR1 P03372 3/20 0.39
▸ ESR2 Q92731 3/20 0.39
▸ ALOX15 P16050 1/20 0.39
▸ CASP1 P29466 1/20 0.39
▸ CASP7 P55210 1/20 0.39
▸ HBB P68871 1/20 0.39
▸ HIF1A Q16665 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ MEN1 O00255 2/20 0.37
▸ KMT2A Q03164 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14069681 1.00 ALDH1A1 (0.43) ALDH1A1TDP1CYP3A4L3MBTL1MAPT
SCHEMBL6846272 0.98 ALDH1A1 (0.42) ALDH1A1TDP1CYP3A4L3MBTL1MAPT
SCHEMBL14515911 0.96 ALDH1A1 (0.43) ALDH1A1TDP1CYP3A4L3MBTL1MAPT
SCHEMBL13658669 0.94 ESR1 (0.45) ALDH1A1TDP1CYP3A4L3MBTL1MAPT
SCHEMBL22129857 0.94 ESR1 (0.45) ALDH1A1TDP1CYP3A4L3MBTL1MAPT
SCHEMBL24177541 0.94 ESR1 (0.45) ALDH1A1TDP1CYP3A4L3MBTL1MAPT
SCHEMBL14111981 0.94 ESR1 (0.45) ALDH1A1TDP1CYP3A4L3MBTL1MAPT
SCHEMBL22793717 0.94 ESR1 (0.45) ALDH1A1TDP1CYP3A4L3MBTL1MAPT
SCHEMBL13020799 0.94 ESR1 (0.45) ALDH1A1TDP1CYP3A4L3MBTL1MAPT
SCHEMBL13657890 0.94 ESR1 (0.45) ALDH1A1TDP1CYP3A4L3MBTL1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 885 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7175922-B2 Aggregate organic light emitting diode devices with improved operational stability EASTMAN KODAK COMPANY (US) 2007-02-13 — — US claimed
US-20060021647-A1 Molecular photovoltaics, method of manufacture and articles derived therefrom SABIC INNOVATIVE PLASTICS IP B.V. 2006-02-02 — — US claimed
US-6967062-B2 White light-emitting OLED device having a blue light-emitting layer doped with an electron-transporting or a hole-transporting material or both EASTMAN KODAK COMPANY (US) 2005-11-22 — — US claimed
US-20050106415-A1 Aggregate organic light emitting diode devices with improved operational stability EASTMAN KODAK COMPANY 2005-05-19 — — US claimed
EP-0468528-B1 Electroluminescent device with organic electroluminescent medium EASTMAN KODAK CO (US) 1995-06-21 — — EP claimed
EP-0468528-A1 Electroluminescent device with organic electroluminescent medium EASTMAN KODAK COMPANY (US) 1992-01-29 — — EP claimed
US-5061569-A SUPERIOR STABILITY EASTMAN KODAK COMPANY (US) 1991-10-29 — — US claimed
US-10934262-B2 Heterocyclic bridged biphenyls UDC IRELAND LIMITED (IE) 2021-03-02 — — US disclosed
EP-3083881-B1 MOLECULAR GLASS MIXTURES FOR ORGANIC ELECTRONICS APPLICATIONS MOLECULAR GLASSES INC (US) 2020-09-09 — — EP disclosed
US-10593886-B2 OLED devices with improved lifetime using non-crystallizable molecular glass mixture hosts MOLECULAR GLASSES, INC. (US) 2020-03-17 — — US disclosed
US-10461269-B2 Crosslinkable, /polymerizable and combinations thereof charge-transporting molecular glass mixtures, luminescent molecular glass mixtures, or combinations thereof for organic light emitting diodes and other organic electronics and photonics applications and method of making same MOLECULAR GLASSES, INC. (US) 2019-10-29 — — US disclosed
EP-2243177-B1 PHOSPHORESCENT OLED HAVING DOUBLE HOLE-BLOCKING LAYERS GLOBAL OLED TECHNOLOGY LLC (US) 2019-05-15 — — EP disclosed
EP-1411561-B1 Oled device having improved light output GLOBAL OLED TECHNOLOGY LLC (US) 2019-03-27 — — EP disclosed
EP-0468440-A2 Organic electroluminescent device with stabilized cathode EASTMAN KODAK COMPANY (US) 1992-01-29 — — EP disclosed
EP-0468438-A2 Organic electroluminescent device with stabilizing fused metal particle cathode EASTMAN KODAK COMPANY (US) 1992-01-29 — — EP disclosed
EP-0468437-A2 Electroluminescent device with improved cathode EASTMAN KODAK COMPANY (a New Jersey corporation) (US) 1992-01-29 — — EP disclosed
EP-0468439-A2 Organic electroluminescent device with stabilizing cathode capping layer EASTMAN KODAK COMPANY (US) 1992-01-29 — — EP disclosed
US-5073446-A ORGANIC ELECTROLUMINESCENT DEVICE WITH STABILIZING FUSED METAL PARTICLE CATHODE EASTMAN KODAK COMPANY (US) 1991-12-17 — — US disclosed
US-5059862-A High stability; compressing aluminum and magnesium EASTMAN KODAK COMPANY (US) 1991-10-22 — — US disclosed
US-5047687-A Organic electroluminescent device with stabilized cathode EASTMAN KODAK COMPANY (US) 1991-09-10 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10934262-B2 Heterocyclic bridged biphenyls BMP2, BPTF, BMP4 ALDH1A1 2127/4885TDP1 3604/4885CYP3A4 2471/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.